Back to Search
Start Over
Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia.
- Source :
-
Current medical science [Curr Med Sci] 2024 Aug; Vol. 44 (4), pp. 799-808. Date of Electronic Publication: 2024 Aug 03. - Publication Year :
- 2024
-
Abstract
- Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.<br />Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Cell viability was detected by Cell Counting Kit-8 (CCK-8) assay, and cell apoptosis and reactive oxygen species (ROS) by flow cytometry. Western blotting was conducted to examine the levels of apoptotic proteins, including cleaved caspase-3 and poly(ADP-ribose) polymerase (PARP). Moreover, the human long noncoding RNA (lncRNA) microarray was used to analyze gene expression after glutamine deprivation, and results were confirmed with quantitative RT-PCR (qRT-PCR). The expression of metallothionein 2A (MT2A) was suppressed using siRNA. Cell growth and apoptosis were further detected by CCK-8 assay and flow cytometry, respectively, in cells with MT2A knockdown.<br />Results: Glutamine deprivation or treatment with BPTES inhibited cell growth and induced apoptosis in SKM-1 cells. The lncRNA microarray result showed that the expression of MT family genes was significantly upregulated after glutamine deprivation. MT2A knockdown increased apoptosis, while proliferation was not affected in SKM-1 cells. In addition, metformin inhibited cell growth and induced apoptosis in SKM-1 cells. Both glutamine deprivation and metformin enhanced the sensitivity of SKM-1 cells to cytarabine. Furthermore, the combination of glutamine deprivation with metformin exhibited synergistic antileukemia effects on SKM-1 cells.<br />Conclusion: Targeting glutamine metabolism in combination with metformin is a promising new therapeutic strategy for AML.<br /> (© 2024. Huazhong University of Science and Technology.)
- Subjects :
- Humans
Cell Line, Tumor
Cell Proliferation drug effects
Cell Survival drug effects
Glutaminase genetics
Glutaminase metabolism
Thiadiazoles pharmacology
Sulfides pharmacology
Drug Synergism
Cytarabine pharmacology
Reactive Oxygen Species metabolism
RNA, Long Noncoding genetics
Metformin pharmacology
Glutamine metabolism
Glutamine pharmacology
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute metabolism
Apoptosis drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2523-899X
- Volume :
- 44
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Current medical science
- Publication Type :
- Academic Journal
- Accession number :
- 39096478
- Full Text :
- https://doi.org/10.1007/s11596-024-2913-z